Viracta Therapeutics
Why Robinhood?
You can watch VIRX and buy or sell other stocks, ETFs, and their options commission-free!About VIRX
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas.
VIRX Key Statistics
Stock Snapshot
As of today, Viracta Therapeutics(VIRX) shares are valued at $0.01. The company's market cap stands at 388.7K, with a P/E ratio of -0.01.
During the trading day, Viracta Therapeutics(VIRX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 491.85K.
Over the past 52 weeks, Viracta Therapeutics(VIRX) stock has traded between a high of $0.58 and a low of $0.01.
Over the past 52 weeks, Viracta Therapeutics(VIRX) stock has traded between a high of $0.58 and a low of $0.01.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.